WVE-120101

WVE-120101 · Wave Life Sciences

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for WVE-120101, covering 2022-02-09 to 2022-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of WVE-120101 in Patients With Huntington's Disease [Phase 1, Phase 2]